Design of a trial to evaluate the impact of clinical pharmacists and community health promoters working with African-Americans and Latinos with Diabetes

BMC Public Health

Volumn 12, Issue 1, 2012, Pages

  Gerber, Ben S ^a,e   Rapacki, Lauren ^a   Castillo, Amparo ^b   Tilton, Jessica ^c   Touchette, Daniel R ^c   Mihailescu, Dan ^d   Berbaum, Michael L ^a   Sharp, Lisa K ^a  

^a Institute for Health Research and Policy   (United States)

^b Midwest Latino Health Research   (United States)

^c Department of Pharmacy Practice ^*  (United States)

^d Section of Endocrinology Diabetes and Metabolism   (United States)

^e JESSE BROWN VA MEDICAL CENTER   (United States)

Author keywords

(3 10): Diabetes mellitus drug therapy; Community health workers; Patient compliance; Patient education; Pharmacists

Indexed keywords

AFRICAN AMERICAN; ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COOPERATION; COST BENEFIT ANALYSIS; CROSSOVER PROCEDURE; ECONOMICS; ETHNOLOGY; FOLLOW UP; HEALTH AUXILIARY; HEALTH PROMOTION; HISPANIC; HUMAN; METHODOLOGY; NON INSULIN DEPENDENT DIABETES MELLITUS; PHARMACIST; PSYCHOLOGICAL ASPECT; RANDOMIZED CONTROLLED TRIAL; SELF CARE; TREATMENT OUTCOME;

AFRICAN AMERICANS; COMMUNITY HEALTH WORKERS; COOPERATIVE BEHAVIOR; COST-BENEFIT ANALYSIS; CROSS-OVER STUDIES; DIABETES MELLITUS, TYPE 2; FOLLOW-UP STUDIES; HEALTH PROMOTION; HISPANIC AMERICANS; HUMANS; PHARMACISTS; RESEARCH DESIGN; SELF CARE; TREATMENT OUTCOME;

MLCS; MLOWN;

EID: 84867681999     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-12-891     Document Type: Article

References (68)

1. Death in the United States, 2009. Minino AM, NCHS Data Brief 2011 64 1 8 22142873
2. Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. Saydah SH, Fradkin J, Cowie CC, JAMA 2004 291 3 335 342 10.1001/jama.291.3.335 14734596 (Pubitemid 38101606)
3. Diabetes prevalence and therapeutic target achievement in the United States, 1999 to 2006. Cheung BM, Ong KL, Cherny SS, Sham PC, Tso AW, Lam KS, Am J Med 2009 122 5 443 453 10.1016/j.amjmed.2008.09.047 19375554
4. Prevalence, treatment, and control of diagnosed diabetes in the U.S. National Health and Nutrition Examination Survey 1999-2004. Ong KL, Cheung BM, Wong LY, Wat NM, Tan KC, Lam KS, Ann Epidemiol 2008 18 3 222 229 10.1016/j.annepidem.2007.10.007 18201902
5. Look AHEAD Research Group: Suboptimal control of glycemia, blood pressure, and LDL cholesterol in overweight adults with diabetes: the Look AHEAD Study. Bertoni AG, Clark JM, Feeney P, Yanovski SZ, Bantle J, Montgomery B, Safford MM, Herman WH, Haffner S, J Diabetes Complications 2008 22 1 1 9 10.1016/j.jdiacomp.2006.10.003 18191071
6. Controlling the ABCs of diabetes in clinical practice: a community-based endocrinology practice experience. Varma S, Boyle LL, Varma MR, Piatt GA, Diabetes Res Clin Pract 2008 80 1 89 95 10.1016/j.diabres.2007.10.029 18160171
7. Prevalence of achievement of A1c, blood pressure, and cholesterol (ABC) goal in veterans with diabetes. Vouri SM, Shaw RF, Waterbury NV, Egge JA, Alexander B, J Manag Care Pharm 2011 17 4 304 312 21534641
8. Racial disparities in diabetes care processes, outcomes, and treatment intensity. Heisler M, Smith DM, Hayward RA, Krein SL, Kerr EA, Med Care 2003 41 11 1221 1232 10.1097/01.MLR.0000093421.64618.9C 14583685
9. Mechanisms for racial and ethnic disparities in glycemic control in middle-aged and older Americans in the health and retirement study. Heisler M, Faul JD, Hayward RA, Langa KM, Blaum C, Weir D, Arch Internal Med 2007 167 17 1853 60 10.1001/archinte.167.17.1853 (Pubitemid 47481480)
10. Ethnic disparities: control of glycemia, blood pressure, and LDL cholesterol among US adults with type 2 diabetes. Kirk JK, Bell RA, Bertoni AG, Arcury TA, Quandt SA, Goff DC Jr, Narayan KM, Ann Pharmacother 2005 39 9 1489 1501 10.1345/aph.1E685 16076917 (Pubitemid 41197131)
11. Disparities in HbA1c levels between African-American and non-Hispanic white adults with diabetes: a meta-analysis. Kirk JK, D'Agostino RB Jr, Bell RA, Passmore LV, Bonds DE, Karter AJ, Narayan KM, Diabetes Care 2006 29 9 2130 2136 10.2337/dc05-1973 16936167 (Pubitemid 44871201)
12. Arcury TA, Quandt SA: Disparities in A1C levels between Hispanic and non-Hispanic white adults with diabetes: a meta-analysis. Kirk JK, Passmore LV, Bell RA, Narayan KM, D'Agostino RB Jr, Diabetes Care 2008 31 2 240 246 17977939 (Pubitemid 351213329)
13. Trends in the control of risk factors for cardiovascular disease among adults with diagnosed diabetes: findings from the National Health and Nutrition Examination Survey 1999-2008*. Ford ES, J Diabetes 2011 3 4 337 347 10.1111/j.1753-0407.2011.00148.x 21767347
14. Non-insulin-dependent diabetes mellitus in minorities in the United States. Carter JS, Pugh JA, Monterrosa A, Ann Intern Med 1996 125 3 221 232 8686981 (Pubitemid 126449266)
15. End-stage renal disease attributable to diabetes mellitus. Perneger TV, Brancati FL, Whelton PK, Klag MJ, Ann Intern Med 1994 121 12 912 918 7978716 (Pubitemid 24370853)
16. Adherence to medication. Osterberg L, Blaschke T, N Engl J Med 2005 353 5 487 97 10.1056/NEJMra050100 16079372 (Pubitemid 41127293)
17. A pharmacist and health promoter team to improve medication adherence among Latinos with diabetes. Gerber BS, Cano AI, Caceres ML, Smith DE, Wilken LA, Michaud JB, Ruggiero LA, Sharp LK, Ann Pharmacother 2010 44 1 70 79 10.1345/aph.1M389 20028957
18. Groningen Initiative to Analyze Type 2 Diabetes Treatment Group: Medication adherence affects treatment modifications in patients with type 2 diabetes. Voorham J, Haaijer-Ruskamp FM, Wolffenbuttel BH, Stolk RP, Denig P, Clin Ther 2011 33 1 121 134 10.1016/j.clinthera.2011.01.024 21397778
19. Primary language, income and the intensification of anti-glycemic medications in managed care: the (TRIAD) study. Duru OK, Bilik D, McEwen LN, Brown AF, Karter AJ, Curb JD, Marrero DG, Lu SE, Rodriguez M, Mangione CM, J Gen Intern Med 2011 26 5 505 511 10.1007/s11606-010-1588-2 21174165
20. Clinical inertia. Phillips LS, Branch WT, Cook CB, Doyle JP, El-Kebbi IM, Gallina DL, Miller CD, Ziemer DC, Barnes CS, Ann Intern Med 2001 135 9 825 34 11694107 (Pubitemid 33051266)
21. Relationship between patient medication adherence and subsequent clinical inertia in type 2 diabetes glycemic management. Grant R, Adams AS, Trinacty CM, Zhang F, Kleinman K, Soumerai SB, Meigs JB, Ross-Degnan D, Diabetes Care 2007 30 4 807 12 10.2337/dc06-2170 17259469 (Pubitemid 46556571)
22. The effects of a nurse case manager and a community health worker team on diabetic control, emergency department visits, and hospitalizations among urban African Americans with type 2 diabetes mellitus: a randomized controlled trial. Gary TL, Batts-Turner M, Yeh HC, Hill-Briggs F, Bone LR, Wang NY, Levine DM, Powe NR, Saudek CD, Hill MN, McGuire M, Brancati FL, Arch Intern Med 2009 169 19 1788 1794 10.1001/archinternmed.2009.338 19858437
23. Supporting diabetes self-care in underserved populations: a randomized pilot study using medical assistant coaches. Ruggiero L, Moadsiri A, Butler P, Oros SM, Berbaum ML, Whitman S, Cintron D, Diabetes Educ 2010 36 1 127 131 10.1177/0145721709355487 20185612
24. Improving diabetes care and health measures among hispanics using community health workers: results from a randomized controlled trial. Babamoto KS, Sey KA, Camilleri AJ, Karlan VJ, Catalasan J, Morisky DE, Health Educ Behav 2009 36 1 113 26 19188371
25. An employer-based, pharmacist intervention model for patients with type 2 diabetes. Iyer R, Coderre P, McKelvey T, Cooper J, Berger J, Moore E, Kushner M, Am J Health Syst Pharm 2010 67 4 312 316 10.2146/ajhp090047 20133537
26. Collaborative drug therapy management for initiating and adjusting insulin therapy in patients with type 2 diabetes mellitus. Rochester CD, Leon N, Dombrowski R, Haines ST, Am J Health Syst Pharm 2010 67 1 42 48 10.2146/ajhp080706 20044368
27. Pharmacist-led group medical appointment model in type 2 diabetes. Taveira TH, Friedmann PD, Cohen LB, Dooley AG, Khatana SA, Pirraglia PA, Wu WC, Diabetes Educ 2010 36 1 109 117 10.1177/0145721709352383 19966072
28. A randomized trial of a primary care-based disease management program to improve cardiovascular risk factors and glycated hemoglobin levels in patients with diabetes. Rothman RL, Malone R, Bryant B, Shintani AK, Crigler B, Dewalt DA, Dittus RS, Weinberger M, Pignone MP, Am J Med 2005 118 3 276 284 10.1016/j.amjmed.2004.09.017 15745726 (Pubitemid 40312639)
29. Interdisciplinary care for diabetic patients with primary care physicians, nurses, and clinical pharmacists: team care of diabetes with nurses and clinical pharmacists in primary care. Willens D, Cripps RJ, Wilson AS, Wolfe K, Rothman R, Clinical Diabetes 2011 29 2 60 68 10.2337/diaclin.29.2.60
30. Improving the Informed Consent Process for Research Subjects with Low Literacy: A Systematic Review. Tamariz L, Palacio A, Robert M, Marcus EN, J Gen Intern Med, published online ahead of print July 11 2012
31. Implementation and evaluation of a low-literacy diabetes education computer multimedia application. Gerber BS, Brodsky IG, Lawless KA, Smolin LI, Arozullah AM, Smith EV, Berbaum ML, Heckerling PS, Eiser AR, Diabetes Care 2005 28 7 1574 80 10.2337/diacare.28.7.1574 15983303 (Pubitemid 40923067)
32. Intent-to-treat analysis for longitudinal studies with drop-outs. Little R, Yau L, Biometrics 1996 52 4 1324 1333 10.2307/2532847 8962456 (Pubitemid 26425283)
33. What is meant by intention to treat analysis? Survey of published randomised controlled trials. Hollis S, Campbell F, BMJ 1999 319 7211 670 674 10.1136/bmj.319.7211.670 10480822 (Pubitemid 29423954)
34. Statistical considerations in the intent-to-treat principle. Lachin JM, Control Clin Trials 2000 21 3 167 189 10.1016/S0197-2456(00)00046-5 10822117 (Pubitemid 30259147)
35. Tabachnick BG, Fidell LS, Using multivariate statistics: 5th ed Boston: Pearson/Allyn & Bacon 2007
36. Muthén LK, Muthén BO, Mplus Statistical Analysis with Latent Variables User's Guide Los Angeles: Muthén & Muthén
37. Care Continuum Alliance (CCA), Definition of Disease Management 2012 [ http://www.carecontinuumalliance.org/dm-definition.asp ]
38. Nutrition recommendations and interventions for diabetes: a position statement of the American Diabetes Association. American Diabetes A, Bantle JP, Wylie-Rosett J, Albright AL, Apovian CM, Clark NG, Franz MJ, Hoogwerf BJ, Lichtenstein AH, Mayer-Davis E, Mooradian AD, Wheeler ML, Diabetes Care 2008 31 1 61 78
39. Physical activity/exercise and type 2 diabetes: a consensus statement from the American Diabetes Association. Sigal RJ, Kenny GP, Wasserman DH, Castaneda-Sceppa C, White RD, Diabetes Care 2006 29 6 1433 1438 10.2337/dc06-9910 16732040 (Pubitemid 44125954)
40. Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M, Peters AL, Tsapas A, Wender R, Matthews DR, American Diabetes Association (ADA), European Association for the Study of Diabetes (EASD), Diabetes Care 2012 35 6 1364 1379 10.2337/dc12-0413 22517736
41. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, et al. JAMA 2003 289 19 2560 2572 10.1001/jama.289.19.2560 12748199 (Pubitemid 37430158)
42. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001 285 2486 2497 10.1001/jama.285.19.2486 11368702
43. Standards of medical care in diabetes - 2012. American Diabetes Association, Diabetes Care 2012 35 1 11 63
44. Hypoglycemia in diabetes. Cryer PE, Davis SN, Shamoon H, Diabetes Care 2003 26 6 1902 1912 10.2337/diacare.26.6.1902 12766131 (Pubitemid 36929141)
45. Community-based Diabetes Education for Latinos: The Diabetes Empowerment Education Program. Castillo A, Giachello A, Bates R, Concha J, Ramirez V, Sanchez C, Pinsker E, Arrom J, Diabetes Educ 2010
46. Training curriculum for health coaches 2012 Available at URL: http://familymedicine.medschool.ucsf.edu/cepc/pdf/ HealthCoachTrainingCurriculumMay08.pdf
47. What do global self-rated health items measure? Krause NM, Jay GM, Med Care 1994 32 9 930 942 10.1097/00005650-199409000-00004 8090045
48. Validation of self-reported health literacy questions among diverse English and Spanish-speaking populations. Sarkar U, Schillinger D, Lopez A, Sudore R, J Gen Intern Med 2011 26 3 265 271 10.1007/s11606-010-1552-1 21057882
49. The Spoken Knowledge in Low Literacy in Diabetes scale: a diabetes knowledge scale for vulnerable patients. Rothman RL, Malone R, Bryant B, Wolfe C, Padgett P, DeWalt DA, Weinberger M, Pignone M, Diabetes Educ 2005 31 2 215 24 10.1177/0145721705275002 15797850 (Pubitemid 40529010)
50. Social support, quality of life, and self-care behaviors amongAfrican Americans with type 2 diabetes. Tang TS, Brown MB, Funnell MM, Anderson RM, Diabetes Educ 2008 34 2 266 276 10.1177/0145721708315680 18375776
51. Testing a self-determination theory process model for promoting glycemic control through diabetes self-management. Williams GC, McGregor HA, Zeldman A, Freedman ZR, Deci EL, Health Psychol 2004 23 1 58 66 14756604 (Pubitemid 38134099)
52. Validating the theoretical structure of the Treatment Self-Regulation Questionnaire (TSRQ) across three different health behaviors. Levesque CS, Williams GC, Elliot D, Pickering MA, Bodenhamer B, Finley PJ, Health Ed Res 2007 22 5 691 702 (Pubitemid 47428958)
53. Reducing the Health Risks of Diabetes: How Self-determination Theory May Help Improve Medication Adherence and Quality of Life. Williams GC, Patrick H, Niemiec CP, Williams LK, Divine G, Lafata JE, Heisler M, Tunceli K, Pladevall M, Diabetes Educ 2009 35 3 484 492 10.1177/0145721709333856 19325022
54. Supporting autonomy to motivate patients with diabetes for glucose control. Williams GC, Freedman ZR, Deci EL, Diabetes Care 1998 21 10 1644 51 10.2337/diacare.21.10.1644 9773724 (Pubitemid 28449801)
55. The summary of diabetes self-care activities measure: results from 7 studies and a revised scale. Toobert DJ, Hampson SE, Glasgow RE, Diabetes Care 2000 23 7 943 950 10.2337/diacare.23.7.943 10895844 (Pubitemid 30480021)
56. Predictive validity of a medication adherence measure in an outpatient setting. Morisky DE, Ang A, Krousel-Wood M, Ward HJ, J Clin Hypertens (Greenwich, Conn) 2008 10 5 348 54 10.1111/j.1751-7176.2008.07572.x
57. Concordance of Medicaid and pharmacy record data in inner-city children with asthma. Mudd KE, Bollinger ME, Hsu VD, Manning A, Tsoukleris MG, Butz AM, Contemp Clin Trials 2008 29 1 13 20 10.1016/j.cct.2007.05.002 17574930 (Pubitemid 350192334)
58. Development of a brief diabetes distress screening instrument. Fisher L, Glasgow RE, Mullan JT, Skaff MM, Polonsky WH, Ann Fam Med 2008 6 3 246 252 10.1370/afm.842 18474888 (Pubitemid 351716784)
59. Gold MR, Cost-effectiveness in health and medicine New York: Oxford University Press 1996
60. Recommendations for reporting cost-effectiveness analyses. Panel on Cost-Effectiveness in Health and Medicine. Siegel JE, Weinstein MC, Russell LB, Gold MR, JAMA 1996 276 16 1339 1341 10.1001/jama.1996.03540160061034 8861994 (Pubitemid 26346934)
61. ISPOR Task Force: Use of pharmacoeconomics information-report of the ISPOR Task Force on use of pharmacoeconomic/health economic information in health-care decision making. Drummond M, Brown R, Fendrick AM, Fullerton P, Neumann P, Taylor R, Barbieri M, Value Health 2003 6 4 407 416 10.1046/j.1524-4733.2003.64245.x 12859580 (Pubitemid 36929727)
62. Cost-effectiveness of intensive glycemic control, intensified hypertension control, and serum cholesterol level reduction for type 2 diabetes. CDC Diabetes Cost-effectiveness Group, JAMA 2002 287 19 2542 2551 10.1001/jama.287.19.2542 12020335
63. Change in Community Pharmacy Practice-It is Not Just Coming from the Cash Register. Goode JV, U.S. Pharm Rev 2006 1 4
64. Status of collaborative drug therapy management in the United States. Am J Health Syst Pharm 2004 61 15 1609 1610 15372838
65. The Pharmacists' Role in the Patient-Centered Medical Home (PCMH): A white paper created by the Health Policy Committee of the Pennsylvania Pharmacists Association (PPA). Berdine H, Dougherty T, Ference J, Karpa K, Klootwyk J, Kozminski M, Leon N, Osborne M, Welch AC, Willey VJ, Peterson A, Stanchak LA, Whisler AG, Ann Pharmacother 2012 46 5 723 750 10.1345/aph.1R189 22535839
66. Outcome effectiveness of community health workers: an integrative literature review. Swider SM, Public Health Nurs 2002 19 1 11 20 10.1046/j.1525-1446.2002.19003.x 11841678
67. American Public Health Association Policy Statement No. 2001-15: Recognition and support for community health workers' contributions to meeting our nation's health care needs. Policy statements adopted by the Governing Council of the American Public Health Association, October 24, 2001. Am J Public Health 2002 92 451 483
68. AADE Position Statement: Community Health Workers in Diabetes Management and Prevention. Albright A, Arujo R, Brownson C, Heffernon D, Shield DI, Maryniuk M, Ruggiero L, Secraw P, Diabetes Educ 2009 35 S3 485 525